TOKYO -- Takeda Pharmaceutical is raising up to 500 billion yen ($4.48 billion) via long-term loans from lenders including Japan's three megabanks to finance its purchase of Irish drug developer Shire.
The Japanese drugmaker said Friday it has signed a deal to obtain the funds from Sumitomo Mitsui Banking, MUFG Bank, Mizuho Bank, Norinchukin Bank and Sumitomo Mitsui Trust Bank. The repayment period is 60 years, but advance payments are allowed after six.
